Christ Hospital in Jersey City, N.J., has rejected a $91.6 million offer from Hudson Hospital Holdco, according to a Jersey Journal report.
The sale of Christ Hospital to Ontario, Calif.-based Prime Healthcare is currently under regulatory review, but Hudson Hospital Holdco sent a letter on Dec. 23 to Christ Hospital, outlining a $91.6 million bid for the financially troubled hospital.
Hudson Hospital Holdco also offered Christ Hospital a $10 million emergency loan, contingent upon the hospital opening negotiations with other potential bidders. The loan would help stabilize the hospital and let it remain open for another 6-10 months while finding the right bidder.
The hospital rejected the offer yesterday and will continue with its pending sale to Prime, which it finds to be “in the best interests of the hospital and the community,” according to a Christ spokesperson cited in the report.
Hudson Hospital Holdco is owned by the principals of Bayonne (N.J.) Medical Center and Hoboken (N.J.) University Medical Center.
Related Articles on Christ Hospital and Hudson Hospital Holdco:
NJ State Officials Won’t Expedite Sale of Christ Hospital to Prime
Sale of NJ’s Hoboken University Medical Center to For-Profit HUMC Holdco Finalized
Christ Hospital in New Jersey Lays Off 50
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
